• Devonian Health Group is trading 45% up at CA$10.14 today, fueled by positive investor sentiment.
  • The surge is attributed to continued progress across the company's clinical development pipeline and strategic developments.
  • This optimistic outlook builds on the impact of the recent 1-for-60 share consolidation, which adjusted the share count.